Gene | WTC | WTJ | TauC | TauJ |
|---|
ADA | 1.06 ± 0.09 | 1.04 ± 0.06 | 3.47 ± 0.42* | 1.35 ± 0.24# |
ADK | 1.02 ± 0.03 | 1.06 ± 0.02 | 1.17 ± 0.06 | 0.85 ± 0.09# |
CD39 | 1.01 ± 0.03 | 1.23 ± 0.02* | 1.45 ± 0.06* | 0.94 ± 0.05# |
CD73 | 1.02 ± 0.04 | 1.23 ± 0.07* | 1.33 ± 0.05* | 1.13 ± 0.05# |
- Mice were treated as indicated (control WT mice, WTC; J4-treated WT mice, WTJ; control Tau22 mice, TauC; and J4-treated Tau22 mice, TauJ; n = 6–9 in each group) from the age of 3–11 months. The hippocampus was harvested carefully and subjected to RT-qPCR. GAPDH was used as a reference gene for normalization. The data are expressed as the mean ± SEM. *p < 0.05 versus the WT vehicle group; #p < 0.05 versus the Tau22 vehicle group
